id
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-03-02 04:57:05
expired found date
-
created at
2024-06-17 05:24:54
updated at
2026-01-06 03:15:59
length
21
crc
61239
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
1
next operation date
2024-12-25 06:43:01
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
44574
mp size raw text
3817
mp inner links count
0
mp inner links status
20 (imported)
title
Home Page
description
Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to…
site name
Thirdrockventures
author
updated
2025-12-27 03:24:39
raw text
Thirdrockventures | Home Page Approach People Portfolio Careers News Contact Approach People Portfolio Careers News Contact Discover. Launch. Build. Transform. ● Recent Highlights Synnovation Therapeutics Synnovation Therapeutics is a precision medicine company developing small molecule therapies optimized to achieve best-in-class pharmacology against highly validated disease targets. Synnovation Therapeutics bluebird bio The FDA announced the approval of bluebird’s Lyfgenia for the treatment of sickle cell disease. Lyfgenia represents one of the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. SCD is a rare, debilitating and life-threatening blood disorder with significant unmet need. Gene therapy holds the promise of delivering more targeted and effective treatments, especially for individuals with rare diseases where the current treatment options are limited. ARTBIO ARTBIO is ...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
2966
text words
507
text unique words
281
text lines
69
text sentences
27
text paragraphs
8
text words per sentence
18
text matched phrases
9
text matched dictionaries
8
links self subdomains
0
links other subdomains
links other domains
6 - synnovationtx.com, artbio.com, rapportrx.com, cargo-tx.com, bioinclusion.org, bluebirdbio.com
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-27 03:24:39
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)
sitemap review version
2
sitemap urls count
149
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-03-02 04:57:05
sitemap process date
2025-03-05 07:05:48
sitemap first import date
-
sitemap last import date
2025-04-17 12:32:18